Life sciences companies challenged by need to minimize health risks without sacrificing data quality during pandemic.
Applied Clinical Trials-02-01-2021
FDA emphasizes importance of inclusion in trials.
President unveils lengthy program for combatting COVID-19 immediately following inauguration.
Click the title above for a link to open the Applied Clinical Trials January/February 2021 issue in an interactive PDF format.
Co-conveners of the newly formed Decentralized Trials & Research Alliance, Amir Kalali, MD and Craig Lipset discuss the alliance as well as how COVID-19 has impacted the industry.
Non-profit biotech organization Cure Rare Disease utilizes collaboration amidst COVID-19 pandemic to catalyze speed of therapeutic research.
A look forward to 2021 for the clinical trials industry.
Hybrid studies, patient-centric tools, and collaborations create big changes for clinical trials and stakeholders during COVID-19.
A compilation of recent notable news developments that pertain to the clinical trials industry.
Cancer still a primary focus of EMA in light of COVID and vaccine development.
2020 Tufts CSDD – IBM Watson Health benchmarking study highlights need for new functionality from EDC solutions and providers.
COVID-19 speeds up clinical research and creates new advancements within industry.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Comparing OpenAI and Mistral on Clinical Trial Matching
2
From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA
3
Embedding AI Across the Clinical Operating Model: Q&A with Rajneesh Patil, Syneos Health
4
Why Outdated Perceptions of APAC Clinical Trial Sites Persist Among Smaller Biotechs
5